Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Full textbook

Catheter-associated urinary infection

Distinguish symptomatic catheter associated infection from expected bacteriuria, collect a valid specimen and coordinate catheter source management with appropriate antimicrobial treatment.

Saved on this device
Open the sections you need. The overview is shown first.
01OverviewDefinition, clinical context and the essential points that orientate the chapter.

A catheter changes both the likelihood of bacterial growth and the meaning of a positive urine test. Organisms can adhere to the device and form biofilm; with prolonged catheterisation, bacteriuria is expected in many patients. Outside pregnancy or a separate mucosa-breaching procedural indication, antibiotics address attributable infection rather than an attempt to maintain sterile urine in a colonised device. This distinction prevents avoidable adverse effects and resistance while preserving prompt treatment for a patient who is genuinely unwell.

Source management is practical as well as microbiological. Check the catheter indication, drainage, tubing and bladder. A blocked device can cause painful retention and may prevent satisfactory treatment. When symptomatic infection develops after more than seven catheter days, consider prompt removal or, if it is still needed, replacement; assess feasibility without delaying antibiotics. Sampling and the first antibiotic dose should be coordinated without creating a treatment delay in severe illness.

Key points

  • Bacteriuria becomes common with an indwelling catheter; a positive culture, cloudy urine or pyuria alone does not establish symptomatic infection.
  • Assess new attributable symptoms and other causes. Before applying the usual no-antibiotic bacteriuria rule, exclude pregnancy and a planned urological procedure that will breach mucosa.
  • With symptomatic infection and a catheter present for more than seven days, consider removal or change as soon as possible; neither action should delay antibiotics.
  • Collect urine aseptically from the sampling port before antibiotics; after a catheter change, take the sample from the new catheter, never the drainage bag.
  • An unblocked catheter and lower-only symptoms may permit a lower UTI drug; fever, flank pain or systemic illness requires an upper tract or sepsis regimen.
  • Review the need for ongoing catheterisation and reassess if symptoms worsen or do not start improving within forty eight hours.
02AetiologyUnderlying causes, associations and risk factors, with why each one matters.
01

Device associated organisms

An indwelling catheter provides a surface on which bacteria can adhere and accumulate. Longer duration and prior antibiotic exposure influence colonisation and the likelihood of resistant organisms.

02

Impaired urinary drainage

Kinking, encrustation or obstruction can impair bladder drainage and promote urinary stasis. Mechanical problems may coexist with symptomatic infection and require direct assessment of the device.

03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.
  1. 1
    Biofilm formation

    Organisms embedded on a catheter surface can persist despite transient suppression in urine. This helps explain why positive cultures recur and why asymptomatic sterilisation attempts are often unsuccessful.

  2. 2
    Mucosal irritation and invasion

    A catheter can irritate the urinary lining, while pathogenic infection can produce additional inflammation and systemic spread. Symptoms and examination are needed to distinguish infection from mechanical discomfort or colonisation.

  3. 3
    Ascending involvement

    Organisms may involve the upper urinary tract, especially when drainage or anatomy is abnormal. Flank pain, fever and organ dysfunction change the syndrome beyond a lower catheter-associated infection.

04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.
Compatible new symptoms

New pelvic or suprapubic discomfort, acute haematuria, fever, rigors, flank pain or systemic deterioration can support catheter associated infection when another source does not better explain them. Compare with the patient’s usual symptoms and function.

Colonisation without illness

An otherwise well person with a longstanding catheter may have cloudy or malodorous urine, pyuria and a positive culture. In a nonpregnant patient with no planned mucosa-breaching urological procedure, those findings alone do not justify antibiotics or cultures to document clearance. Pregnancy and the relevant procedural indication require separate treatment decisions.

Blocked drainage or sepsisRed flag

A painful distended bladder, little urine in the bag despite bladder filling, hypotension, altered consciousness or rigors requires urgent assessment. Check for obstruction and systemic illness while arranging necessary treatment.

05InvestigationsWhat to request, why it matters and how to interpret it.
Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

  1. 01
    Aseptic catheter port urine cultureFirst step
    Why
    Obtain a specimen that represents current bladder urine.
    Interpretation and limitations
    Collect from a disinfected sampling port before antibiotics, avoiding the collection bag. If the catheter is changed first, sample the newly inserted catheter; if it is removed, collect an appropriate midstream specimen instead.
  2. 02
    Catheter and bladder assessment
    Why
    Identify mechanical failure that may require immediate source management.
    Interpretation and limitations
    Check the indication, insertion date, tubing position, drainage and suprapubic findings. Use bladder scanning when retention is uncertain; a blocked catheter requires action, not just interpretation of a positive culture.
  3. 03
    Severity guided blood investigations
    Why
    Determine whether infection is associated with systemic organ effects.
    Interpretation and limitations
    Obtain renal function and other blood tests according to illness severity, with lactate and blood cultures for suspected sepsis. Recent catheterisation or antibiotics can influence both resistance risk and the organisms recovered.
  4. 04
    Imaging for upper tract complications
    Why
    Investigate a suspected obstructed or persistent upper tract source.
    Interpretation and limitations
    Flank pain, renal deterioration or failure to improve can justify ultrasound or cross sectional imaging. Imaging should answer a source-control question rather than being ordered routinely for asymptomatic catheter bacteriuria.
06Differential diagnosisRealistic alternatives and the features that help distinguish them.
01

Asymptomatic bacteriuria

Bacterial growth without attributable symptoms is common with prolonged catheter use. Cloudiness, smell or pyuria alone cannot reliably distinguish colonisation from a symptomatic urinary infection.

02

Mechanical catheter obstruction

A poorly draining catheter can cause pain, bladder distension and agitation without infection. Checking tubing and bladder filling helps identify a problem that requires restoration of drainage.

03

Nonurinary delirium or sepsis

Medication effects, dehydration, constipation and other infections can produce confusion or physiological decline. Incidental bacteriuria should not prematurely close the investigation of these competing explanations.

Additional chapter-specific clues

Delirium needs a differential

New delirium may accompany infection but is not proof that the urine is the source. Assess hydration, medicines, pain, constipation, hypoxia and other infections, and interpret urinary findings within the complete examination.

07ManagementImmediate care, first-line treatment, alternatives and escalation.
01Worked caseCoordinate change culture and treatmentFirst stepA sixty eight year old woman has new suprapubic pain after twelve days with a catheter.
  1. 1AlternativeThe catheter is still needed during recovery from postoperative bladder dysfunction. She is afebrile with stable observations, no flank pain, eGFR 61 and no relevant allergy or G6PD deficiency; examination finds no alternative cause and confirms drainage without upper tract features.
  2. 2Because the catheter has been present for more than seven days, it is changed aseptically without delaying treatment. Urine is collected from the new catheter port before nitrofurantoin modified release 100 mg orally twice daily for seven days is started for the lower-only syndrome.
  3. 3Culture identifies susceptible Escherichia coli. Within forty eight hours the suprapubic discomfort resolves and drainage remains satisfactory, so she continues the selected course without an additional antibiotic or routine repeat culture.
  4. 4The surgical team reviews her bladder function and later removes the catheter when it is no longer needed. She voids satisfactorily and remains symptom-free; the result records both recovery from infection and removal of the continuing device risk.
02Asymptomatic findingAvoid treating a culture in isolationA patient feels well but a catheter urine report shows bacterial growth.
  1. 1Confirm the absence of new attributable symptoms or systemic signs, and specifically check pregnancy status and any planned urological procedure that will breach mucosa. The usual no-antibiotic pathway applies only after those exceptions have been excluded. Review why the sample was requested and examine if the clinical state is uncertain.
  2. 2Do not prescribe antibiotics solely for cloudy urine, odour, pyuria or bacterial growth. Explain that colonisation is common and that repeated treatment is unlikely to produce lasting sterile urine while the catheter remains.
  3. 3Continue appropriate catheter care and review whether the device is needed. New symptoms reopen the infection assessment; detected significant bacteriuria in pregnancy or before a mucosa-breaching procedure instead requires the appropriate culture-guided maternity or urological plan.
03Systemic presentationTreat illness and address the deviceThe patient has fever, flank pain or deteriorating physiology alongside possible urinary infection.
  1. 1Assess for sepsis, obtain relevant cultures promptly and start an appropriate systemic regimen. Arrange catheter removal or change when indicated, but do not hold urgent antibiotics while waiting for a difficult replacement.
  2. 2If the catheter is blocked, arrange prompt restoration of drainage with suitable expertise. Persistent upper tract obstruction or a collection may need urological or radiological intervention beyond changing the bladder catheter.
  3. 3At forty eight hours review the organism, susceptibility, clinical response, oral tolerance and source control. Use the upper tract or sepsis duration appropriate to that syndrome, rather than automatically applying a lower-only seven day course.
Key medicines and prescribing safety2 treatments · regimens, roles and cautions
A NICE option when eGFR is at least 45 and upper tract or prostate infection is not suspected.

Nitrofurantoin 100 mg modified release capsules

For an adult with an unblocked catheter and lower-only symptomatic infection, give 100 mg orally twice daily for seven days with food.

A blocked catheter needs drainage, and upper tract or prostate involvement requires another antibiotic strategy. Standard use requires eGFR at least 45 ml/min/1.73 m²; the resistant uncomplicated lower-infection exception at 30–44 needs an individual benefit–risk decision. Exclude G6PD deficiency, acute porphyria, nitrofuran or formulation hypersensitivity, and pregnancy at term, during labour or delivery. Reconcile citrate or other urinary alkalinisers, magnesium trisilicate and probenecid or sulfinpyrazone because activity, absorption or excretion can be affected. Stop and investigate new respiratory, hepatic or neurological symptoms promptly. Verify the modified release capsule; this seven-day treatment does not establish a long-term prophylaxis plan.

A NICE upper tract oral option, selected using severity, susceptibility and the ability to absorb treatment.

Cefalexin 500 mg capsules

For catheter associated infection with upper tract symptoms in an adult suitable for oral therapy, use 500 mg orally twice or three times daily for seven to ten days.

Severe illness, vomiting or suspected sepsis can require intravenous treatment and hospital care instead. Exclude allergy to cefalexin, its excipients or the cephalosporin class; clarify any penicillin reaction and seek specialist selection after a severe reaction. Check renal dose adjustment and previous resistant isolates. Monitor for antibiotic-associated diarrhoea, severe rash and neurological effects with accumulation; the named formulation does not remove the need to individualise treatment in renal impairment.

08ComplicationsImportant consequences, why they occur and why they matter clinically.
01

Upper tract infection

Catheter associated infection can extend beyond the bladder and produce pyelonephritis. New flank symptoms or systemic illness require treatment with suitable tissue activity and assessment for complications.

02

Bacteraemia and organ dysfunction

Invasive infection can lead to circulatory or renal deterioration. Urgent treatment and source assessment are needed when the patient’s physiology indicates more than local urinary symptoms.

03

Resistance and drug harm

Unnecessary courses for colonisation can select resistant organisms and cause antibiotic-associated adverse effects. Subsequent genuine infection may then be harder to treat safely and effectively.

09Monitoring and follow-upTreatment response, safety checks and longer-term review.
  • Document the catheter’s insertion date, continuing indication and the planned removal or replacement action, so device management is not lost during antibiotic handover.
  • Make the specimen source explicit on the request and clinical record, including whether it came from a new catheter, an existing port or a midstream sample after removal.
  • Reassess symptoms and observations if the patient worsens or fails to improve within forty eight hours; check patency and alternative infection sources as well as resistance.
  • Stop routine surveillance cultures when there is no clinical indication. Record recovery through symptoms, physiology and successful drainage rather than requiring a sterile culture from every catheterised patient.
10Special situationsVariants, exceptions and circumstances that change the usual approach.

Biofilm changes interpretation

Organisms on a catheter can persist despite antibiotics, making repeated attempts at microbiological eradication unhelpful in an asymptomatic patient outside pregnancy or a separate procedural indication. Removing an unnecessary device addresses the continuing exposure more directly.

A port is not a bag

The drainage bag contains urine that has accumulated and may be contaminated. Aseptic port sampling, or sampling from a new catheter after change, makes the culture more useful for the present treatment decision.

Timing is coordinated

Changing an old catheter and obtaining a fresh specimen are sensible source and diagnostic actions. In a patient with sepsis they must be organised alongside antibiotics, because a replacement delay is not a reason to defer urgently needed treatment.

Procedure exceptions are specific

Bacteriuria management before a mucosa-breaching urological procedure differs from routine long-term catheter care. Do not extend that exception to every uncomplicated catheter change or prescribe routine antibiotic prophylaxis without a separate indication.

11Common pitfallsFrequent interpretation and management errors.
  1. 01

    Prescribing for urine odour alone confuses a common catheter finding with a symptomatic infection and may distract from the reason the patient actually feels unwell.

  2. 02

    Sending a drainage-bag culture creates an avoidable specimen-quality problem and can lead to treatment of organisms that do not explain the current illness.

  3. 03

    Delaying sepsis antibiotics until a specialist can replace the catheter converts a useful source-control step into an unsafe bottleneck.

  4. 04

    Assuming that a changed catheter completes source control can miss an infected upper tract obstruction, persistent abscess or another nonurinary focus.

Practice

Two practice questions

Question 1 of 20 correct
UrologyOriginal SBA

Interpret catheter bacteriuria

An 81 year old care-home resident has a long-term catheter. Staff send urine because it smells stronger; culture grows Escherichia coli. He has no new pain, fever, delirium or systemic change, and drainage is normal. No invasive urological procedure is planned. What is the best management?

Sources and review status7 sources · checked 8 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 8 Sept 2026; clinical approval remains outstanding.

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom